Phase III clinical trial - Gynécologie - Col utérus

SENTICOL III
Gynécologie - Col utérus
Ouvert depuis le: 07.09.2020
Site: Paris
Public cible
Adulte
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
Description de l'essai

SENTICOL III is large prospective multicenter international randomized study designed to validate the Sentinel Lymph Node (SLN) mapping technique in early cervical cancer. This "validation study" will compare the outcome of patients with negative SLN (experimental arm) vs patients with negative SLN + Pelvic Lymph Node dissection (PLN)(reference arm).